Rademikibart
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-P990090-1MG | 1 mg | Inquire | ||
| HY-P990090-5MG | 5 mg | Inquire | ||
| HY-P990090-10MG | 10 mg | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Rademikibart (CBP-201) is a human monoclonal antibody targeting IL-4Rα with a KD of 20.7 pM when binding to human IL-4Rα epitopes. Rademikibart does not bind to IL-4Rα from other species. Rademikibart inhibits IL-4 and IL-13-mediated STAT6 signaling, TF-1 cell proliferation and TARC production in PBMCs. Rademikibart has the potential for moderate-to-severe Th2 inflammatory diseases research[1].
| Category | Antibody |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Inflammation/Immunology, Immunology/Inflammation |
| Format | Solubility: 10 mM in DMSO |
| Grade | Clinical information: Phase 3 |
| CAS-Number | 2648260-80-2 |
| Product Line | Biosimilar |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room temperature |
| Material Safety Data Sheet | Download PDF |
